Whereas preemptive screening for the presence of lymph node and lung metastases is
standard-of-care in thyroid cancer patients, bone metastases are less well studied and are …

Bone represents the second most common site of distant metastases in differentiated thyroid
cancer (DTC). The clinical course of DTC patients with bone metastases (BM) is quite …

Abstract Purpose and Patients The MOS CA. TI.(Metastases of the Skeleton from CArcinoma
of the ThyroId) is a multicenter, retrospective study investigating the real-life outcome and …

BACKGROUND: The treatment of bone metastasis in association with thyroid cancer
represents a difficult challenge. Given the paucity of patients with bone metastasis and the …

Background Thyroid cancer is the fastest growing cancer in the United States. A small
portion of differentiated thyroid cancers (DTCs; 2% to 13%) develop bone metastases, which …

The presence of distant metastases from differentiated thyroid carcinoma decreases the 10-
year survival of patients by 50%. Bone metastases represent a frequent complication …

Purpose Bone metastases (BM) from differentiated thyroid carcinoma (DTC) impact
negatively the quality of life and the life expectancy of patients. The aim of the study was (a) …

Simple Summary Patients with bone metastases (BMs) from differentiated thyroid carcinoma
(DTC) can live longer than those with BMs from other cancers. BMs from DTC create …

Summary objective Surgery of bone metastases from differentiated thyroid carcinoma seems
indicated in individual patients. This study was performed (1) to analyse retrospectively …

Data for patients with bone metastases (BMs) of differentiated thyroid carcinoma (DTC) were
retrospectively studied to identify factors associated with survival. We especially studied the …